SWE ORPHAN BIOVITRU (B6E MU) stock market data APIs
€35.762
0.35(1%)
as of March 18, 2026
Try our APIs with
free plan!
SWE ORPHAN BIOVITRU Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for B6E.MU.
Prev. Close
35.762
Open
36.1108
High
36.2519
Low
35.6855
52 wk Range
22.96-40.08
Market Cap
5 414 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SWE ORPHAN BIOVITRU data using free add-ons & libraries
Get SWE ORPHAN BIOVITRU Fundamental Data
SWE ORPHAN BIOVITRU Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SWE ORPHAN BIOVITRU News
New
Sobi Capital Markets Day 2026: Bringing brilliant ideas to life and building the next chapter with ambition to deliver SEK 55bn by 2030
STOCKHOLM, Feb. 18, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today hosts its Capital Markets Day, where senior management will provide an update on the company's strategy and outline its new mid-term ...
Sobi’s Arthrosi Deal Brings Late Stage Gout Asset Into Focus
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Swedish Orphan Biovitrum (OM:SOBI) has completed its acquisition of Arthrosi Th...
Sobi to host a Capital Markets Day on 18 February 2026
STOCKHOLM, Feb. 11, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (Sobi) invites investors, analysts, and other stakeholders to its upcoming Capital Markets Day (CMD), which will be held in person ...
Sobi completes acquisition of Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi b...
Get SWE ORPHAN BIOVITRU fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
